Conferences this month

6 November 2001

- The Center for Business Intelligence is holding a conference onGeneric Drugs on November 29-30 in Washington, DC. One of the speakers will be Senator Henry Waxman. Further details are available from Glen Mansaeu, phone (in USA): 800 767 9499; fax: +1 781 939 2466; e-mail:glenm@cbinet.com, mentioning priority code HB169PR;

- The full cost of developing a new prescription drug will be discussed at a meeting on November 30, held in Philadelphia, Pennsylvania. Speakers include Merck & Co chief executive Raymond Gilmartin. Details are available from the Tufts Center for the Study of Drug Development, fax: +1 617 636 2425.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight